A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

发表于昨天 22:20

期刊：Science Translational Medicine

文献作者：Laura R. Saunders; Alexander J. Bankovich; Wade C. Anderson; Monette A. Aujay; Sheila Bheddah; KristenAnn Black; Radhika Desai; Paul A. Escarpe; Johannes Hampl; Amy Laysang; David Liu; Javier Lopez-Molina; Milly Milton; Albert Park; Marybeth A. Pysz; Hui Shao; Brian Slingerland; Michael Torgov; Samuel A. Williams; Orit Foord; Philip Howard; Jacek Jassem; Andrzej Badzio; Piotr Czapiewski; David H. Harpole; Afshin Dowlati; Pierre P. Massion; William D. Travis; M. Catherine Pietanza; J. T. Poirier; Charles M. Rudin; Robert A. Stull; Scott J. Dylla

出版日期：2015-8-26

DOI号：10.1126/scitranslmed.aac9459

下载链接：https://www.science.org/doi/pdf/10.1126/scitranslmed.aac9459

文献链接：https://doi.org/10.1126/scitranslmed.aac9459

当前文献来源于 American Association for the Advancement of Science (AAAS)。

备注信息：

[AAAS] A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[AAAS] A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo 一键复制

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[AAAS] A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo